|
|||||
|
|
Prevalence and significance of CYP2C19*2 and CYP2C19*17 alleles in a New Zealand acute coronary syndrome population |
|
| Authors: | P. D. Larsen L. R. Johnston A. Holley A. C. La Flamme L. Smyth E. W. Chua M. A. Kennedy S. A. Harding |
| Affiliation: | 1. Wellington Cardiovascular Research Group, Wellington Hospital, Wellington, New Zealand;2. Department of Surgery and Anaesthesia, University of Otago, Wellington, New Zealand;3. School of Biological Sciences, Victoria University of Wellington, Wellington, New Zealand;4. Carney Centre for Pharmacogenomics, University of Otago, Christchurch, New Zealand;5. Cardiology Department, Wellington Hospital, Wellington, New Zealand |
| Abstract: | |
| Keywords: | platelet activation/drug effect acute coronary syndrome ticlopidine/*analogue and derivative ticlopidine/therapeutic use ethnicity |